Zacks Investment Research on MSN
PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced innovations to its Revio and Vega platforms last week. The innovations are expected to lower sequencing costs, add ...
MENLO PARK, Calif., Feb. 5, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced two new high throughput library ...
The company said the new chemistry could decrease sequencing costs for high-throughput users by up to 40%, lowering the ...
MENLO PARK, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the Vega™ system, the company’s first ...
MENLO PARK, Calif., Oct. 31, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has begun taking orders for its ...
PacBio (PACB), a leading developer of high-quality, highly accurate genomic sequencing solutions, today announced the inclusion of the Onso short-read sequencing platform in the 10x Genomics ...
MENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a significant advancement for ...
By supporting sample prep across low-pass WGS, plasmid sequencing, and microbial sequencing, LongPlex extends options for researchers working in diverse fields. Its streamlined indexed tagmentation ...
Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other ...
Zacks Investment Research on MSN
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product ...
MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on ...
New Library Preparation Solutions Offer Never Before Achieved Scale for the Revio™ Sequencing System MENLO PARK, Calif., Feb. 5, 2024 /PRNewswire/ -- PacBio (PACB) (NASDAQ: PACB), a leading developer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback